CARLSBAD, Calif., May 21, 2012 /PRNewswire/ -- The Life Technologies Foundation, the philanthropic arm of Life Technologies Corporation (NASDAQ: LIFE), today announced it is the lead sponsor of a planned Smithsonian Institution exhibit to celebrate the 10th anniversary of the Human Genome Project – the landmark scientific milestone that opened the door to today's genomic revolution. Scheduled to open in 2013, the interactive display is being developed by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), and the National Museum of Natural History (NMNH).
Life Technologies' DNA sequencing instruments played a critical role in the Human Genome Project, an international endeavor launched in 1990 to map the 6 billion base pairs in a single human genome. Completed in 2003, the daring initiative laid the foundation for better understanding the role genetics play in health and disease. Much of what has been learned as a result is now being applied in biomedical research to guide treatment.
"We are at an inflection point in the history of biology. What science has taught us about genomics in the last 10 years will undoubtedly be dwarfed by the revolutionary advancements to come," said Gregory T. Lucier, Chairman and Chief Executive Officer of Life Technologies. "The goal of the Life Technologies Foundation through its lead sponsorship is to educate visitors to this exhibit on the powerful information we can now unlock within their DNA as a result of the Human Genome Project, and the impact it will have in medicine and their daily lives."
The exhibit will expose visitors to the future of genomics and a broad range of themes associated with the genomics revolution, including: major breakthroughs in genomic science such as links between genes and disease; cutting-edge work in genomically guided drug therapies for application in personalized medicine; and ethical, legal and social issues related to advances in the field.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV